Ablynx Banks $200M IPO in Nasdaq Debut Post author:Sam Post published:October 24, 2017 Post category:BioPharma Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace You Might Also Like Esperion's Cholesterol Drug Positive in PhIII Trial March 6, 2018 Reported Side Effects Raise Concerns for Regeneron’s Eylea February 21, 2018 Roche, Shire Patent Fight Escalates Over Haemophilia Drug December 18, 2017
